Abstract【Objective】 To evaluate the efficacy of parathyroidectomy combined with anterior wall autotransplantation (tPTX+AT) in the treatment of maintenance hemodialysis (MHD) patients with severe secondary hyperparathyroidism (SPTH), and investigate the effect on soluble Klotho protein and fibroblast growth factor 23 (FGF23) levels. 【Methods】 Ninety patients complicated with MHD and SPTH, who underwent tPTX+AT treatment, were enrolled in the study. The incidence of complications, biochemical parameters, Klotho and FGF23 levels before and 1, 3, 6 and 12 months after treatment were recorded. 【Results】 All patients underwent successful operation. There were 3 cases of postoperative hemorrhage, 2 cases with postoperative infection, 1 case with laryngeal nerve injury, 1 case with arrhythmia, 4 cases with hypocalcemia, and 1 case with high potassium. All of them got improved after active treatment. The levels of serum calcium, blood phosphorus, calcium and phosphorus product, iPTH and ALP at 1, 3, 6 and 12 months after surgery were lower than those before treatment (P<0.05). At 3, 6, and 12 months after surgery, Hb, Hct, and SF were higher than those before surgery (P<0.05). While the dose of rHuEPO and CRP were lower than those before surgery (P<0.05). There was no significant difference in Kt/V (urea clearance index) before and after surgery (P>0.05). FGF-23 in patients at 1, 3, 6 and 12 months after surgery was lower than that before surgery, and Klotho was higher than that before surgery (P<0.05). 【Conclusion】 tPTX+AT has less complication in MHD with SPTH patients and high safety. It can improve calcium metabolism, correct nutrition and inflammation status, and can reduce FGF-23 and increase Klotho level.
TONG Chang-jun,LIU Yong,ZHOU Jia-jun, et al. Effect of Parathyroidectomy Combined with Autotransplantation on Klotho and FGF23 in Maintenance Hemodialysis Patients[J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(10): 1494-1496.
[1] Chen JB. Association between clinical variables and mortality after parathyroidectomy in maintenance hemodialysis patients[J].Am J Surg,2017,213(1):140-145. [2] 陈高帜,李校堃.FGF23/α-Klotho信号传导的分子机制[J].生物产业技术,2018,9(5):69-74. [3] 徐艳,徐耀,刘昌华.Klotho蛋白对慢性肾脏病钙磷代谢的影响[J].中国医师杂志,2018,20(10):1594-1597. [4] 王莉,李贵森,刘志红.中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J].肾脏病与透析肾移植杂志,2013,22(6):554-559.[5] Eidman KE, Wetmore JB. The role of parathyroidectomy in the management of secondary hyperparathyroidism[J].Curr Opin Nepl Hypertens,2017,26(6):516-522. [6] Erben RG. Pleiotropic Actions of FGF23[J].Toxicol Pathol,2017,45(7):904-910. [7] Lu X, Hu MC. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease[J].Kidney Dis (Basel),2017,3(1):15-23. [8] 侯爱珍,娄探奇,肖观清, 等.甲状旁腺切除术对维持性血液透析患者成纤维细胞生长因子23的影响[J].中华肾脏病杂志,2017,33(10):757-762. [9] Liao SC, Moi SH, Chou FF, et al. Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy[J].Biomed Res Int,2016,2016:6453803. [10] 赵铁柱,王素霞.甲状旁腺切除术对维持性血液透析病人预后的影响[J].内蒙古医科大学学报,2019,41(1):86-88.
2020, Vol. 37 
